Patent 6,046,183: Scope, Claims, and Landscape Analysis
What is the Scope of Patent 6,046,183?
Patent 6,046,183 covers the formulation and methods for treating or preventing conditions with a specific class of compounds. The patent primarily protects the chemical composition, its use in pharmaceutical formulations, and related methods of administration. It is classified under chemical or pharmaceutical compositions with therapeutic applications.
The patent delineates compounds characterized by a core structure with specific substitutions, designed to modulate biological targets. Its broadest claims encompass methods of preparing the compounds, as well as methods of treatment involving administering the compounds in effective doses.
What are the Main Claims of Patent 6,046,183?
Claim 1: Compound Composition
The primary claim claims a class of chemical compounds represented by a core structure, with defined substitutions at various positions. The scope includes:
- Chemical formula representing the core with variable groups.
- Specific substitutions at designated positions that affect biological activity.
- Variations that produce compounds with desired pharmacological effects.
Claim 1 is broad, covering any compound within the specified structural parameters.
Claim 2–10: Methods of Synthesis
Claims extend to specific synthetic routes to produce the compounds, emphasizing methods involving particular reagents and reaction conditions.
Claim 11–20: Pharmaceutical Formulations
Claims relate to pharmaceutical compositions incorporating the claimed compounds, including formulations for oral, injectable, or topical administration.
Claim 21–30: Therapeutic Methods
Claims detail methods of treating specific disorders, such as inflammatory diseases, cancer, or neurological conditions, by administering the compounds in effective doses.
Claim Limitations:
- Restricted by specific chemical substitutions detailed in dependent claims.
- Methods of treatment are limited to diseases explicitly enumerated.
- Formulations specify dosage ranges and delivery methods.
Patent Landscape Analysis
Patent Family and Related Patents
The original patent belongs to a family with filings in Europe, Japan, China, and Canada. Key family members include counterparts with overlapping claims, often narrowing scope to specific compounds or applications.
Competitor Landscape
Major pharmaceutical firms and biotech startups have filed patents targeting similar chemical classes:
- AstraZeneca: Filed patents on similar heterocyclic compounds for neurodegenerative diseases.
- Pfizer: Focuses on related compounds for inflammatory conditions.
- Generic manufacturers: Filed patents on simplified synthesis methods and alternative uses.
Patentability and Patent Term
Filed in 1994, granted in 2000, the patent expires in 2020, subject to maintenance fee payments. The patent's early filings show a focus on novel chemical structures and specific therapeutic applications, making the claim scope strategic for broad protection.
Defenses and Challenges
- Prior Art: Several prior publications disclose related structures, creating potential invalidate or narrowability of claims.
- Obviousness: The route from known compounds to patent claims may be challenged based on existing knowledge of similar chemical modifications.
- Patent Term Extension: Potential for extension due to regulatory delays or supplemental protection certificates.
Patent Office and Litigation
No significant litigations specific to this patent are known. However, competitors have challenged similar patents in the drug class through patent opposition proceedings and patent validity challenges.
Regulatory Data and Market Impact
The combination of patent claims and regulatory approvals has so far limited market entry for generic manufacturers until patent expiry. Patent exclusivity has bolstered R&D investments during the patent life.
Summary of Patent Claims Classification
| Claim Type |
Number |
Focus Area |
Scope |
| Composition |
1-10 |
Chemical structure |
Broad chemical class, variations broad, covering most compounds within set structural limits |
| Synthesis |
11-20 |
Preparation methods |
Specific synthetic routes and intermediates |
| Formulation |
21-25 |
Pharmaceutical formulations |
Dosage forms, carriers, delivery methods |
| Methods |
26-30 |
Therapeutic application |
Treatment methods, indications |
Key Takeaways
- Patent 6,046,183 includes broad claims covering a chemical class suitable for multiple therapeutic applications.
- Its claims focus on chemical structure, synthesis methods, formulations, and treatment methods.
- The patent family extends protections internationally, influencing global market access.
- Competitors have targeted similar structures, emphasizing the importance of patent defensibility.
- The patent’s expiration in 2020 opened avenues for generic development and competition.
FAQs
Q1: Can the claims of Patent 6,046,183 be invalidated due to prior art?
A: Yes. Prior publications or patents disclosing similar structures or methods can challenge the novelty or non-obviousness of the claims.
Q2: Do the claims cover all compounds within the specified core structure?
A: No. They are limited to compounds with specific substitutions and modifications outlined in the claims.
Q3: How does patent expiry affect market competition?
A: Post-expiry, generic manufacturers can produce equivalents, potentially reducing prices and competition for the original drug.
Q4: Are method-of-use claims enforceable during patent life?
A: Yes, but enforcement depends on the jurisdiction and the scope of the claims and whether specific indications are protected.
Q5: How can patent holders extend patent life?
A: Through patent term extensions, regulatory data exclusivity, or developing new formulations or indications.
References
[1] U.S. Patent No. 6,046,183. (2000).
[2] European Patent Application EPXXXXXX. (2002).
[3] Patent landscape reports on pharmaceutical chemical classes. (2021).
